Aliso Viejo, United States
Glaukos Corporation, a company founded in 1998, is making significant strides in the field of healthcare, specifically within the realms of chronic eye disease treatment. With the bold slogan, "Pioneering new treatments for chronic eye diseases," the company is deeply engaged in the development of innovative therapies targeting glaucoma, corneal disorders, and retinal diseases. These advancements aim to enhance current treatment protocols and improve patient quality of life globally.
Headquartered in the United States, Glaukos Corporation is well-positioned within the Health Care and Health and Wellness industries. The company received a substantial $30.00M Series F investment on 07 February 2013, showcasing notable investor confidence. The investment round was led by a diverse cohort of reputable firms including InterWest Partners, Montreux Equity Partners, Domain Associates, Frazier Healthcare Partners, Meritech Capital Partners, OrbiMed, and Versant Ventures.
